Show simple item record

dc.creatorKissler, Stephen M.
dc.creatorKishore, Nishant
dc.creatorPrabhu, Malavika
dc.creatorGoffman, Dena
dc.creatorBeilin, Yaakov
dc.creatorLandau, Ruth
dc.creatorGyamfi-Bannerman, Cynthia
dc.creatorBateman, Brian T.
dc.creatorRazavi, Armin S.
dc.creatorKatz, Daniel
dc.creatorGal, Jonathan
dc.creatorBianco, Angela
dc.creatorStone, Joanne
dc.creatorLarremore, Daniel
dc.creatorBuckee, Caroline O.
dc.creatorGrad, Yonatan H.
dc.date.accessioned2020-09-18T15:25:57Z
dc.date.available2020-09-18T15:25:57Z
dc.date.created2020
dc.identifier.issn2041-1723spa
dc.identifier.otherhttps://doi.org/10.1038/s41467-020-18271-5spa
dc.identifier.urihttp://hdl.handle.net/20.500.12010/13454
dc.description.abstractSARS-CoV-2-related mortality and hospitalizations differ substantially between New York City neighborhoods. Mitigation efforts require knowing the extent to which these disparities reflect differences in prevalence and understanding the associated drivers. Here, we report the prevalence of SARS-CoV-2 in New York City boroughs inferred using tests administered to 1,746 pregnant women hospitalized for delivery between March 22nd and May 3rd, 2020. We also assess the relationship between prevalence and commuting-style movements into and out of each borough. Prevalence ranged from 11.3% (95% credible interval [8.9%, 13.9%]) in Manhattan to 26.0% (15.3%, 38.9%) in South Queens, with an estimated citywide prevalence of 15.6% (13.9%, 17.4%). Prevalence was lowest in boroughs with the greatest reductions in morning movements out of and evening movements into the borough (Pearson R = −0.88 [−0.52, −0.99]). Widespread testing is needed to further specify disparities in prevalence and assess the risk of future outbreaks.spa
dc.format.extent6 páginasspa
dc.format.mimetypeapplication/pdfspa
dc.language.isoengspa
dc.publisherNature communicationsspa
dc.sourcereponame:Expeditio Repositorio Institucional UJTLspa
dc.sourceinstname:Universidad de Bogotá Jorge Tadeo Lozanospa
dc.subjectSARS-CoV-2spa
dc.subjectNew York Cityspa
dc.titleReductions in commuting mobility correlate with geographic differences in SARS-CoV-2 prevalence in New York Cityeng
dc.type.localArtículospa
dc.subject.lembSíndrome respiratorio agudo gravespa
dc.subject.lembCOVID-19spa
dc.subject.lembSARS-CoV-2spa
dc.subject.lembCoronavirusspa
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessspa
dc.type.hasversioninfo:eu-repo/semantics/acceptedVersionspa
dc.rights.localAbierto (Texto Completo)spa
dc.identifier.doihttps://doi.org/10.1038/s41467-020-18271-5spa
dc.type.coarhttp://purl.org/coar/resource_type/c_2df8fbb1spa


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record